# XP Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xp-health

- Industry: Healthcare
- Headquarters: San Carlos, US
- Website: www.xphealth.co
- Total disclosed funding: $47M
- Latest round: Series B (Aug 23, 2024)
- Investors on record: 14

## About

XP Health, Inc. is a US-based provider of a digital-first vision care platform that modernizes vision programs, enhancing accessibility and user engagement through AI technology.XP Health, Inc. was founded in 2018 and is headquartered in San Carlos, California, US. The company operates a digital-first vision care platform that simplifies access to vision care for its users. The founders of the company, Antonio Moraes and James Wong, have prior entrepreneurial experience. In August 2024, XP Health raised USD 25.20 mn in Series B funding, led by QED Investors with participation from multiple investors including American Family Ventures and Canvas Ventures, bringing the total amount raised to USD 25.20 mn.XP Health offers a digital-first vision care platform designed to modernize vision programs. Their core product streamlines the process of accessing vision care, whether online or in-person, effectively overcoming the traditional complexities associated with such programs. The platform utilizes AI technology to personalize the glasses-buying experience, thereby reducing the expenses typically incurred from retail overhead. This service enhances user engagement and satisfaction, simplifying the utilization of vision care benefits for both consumers and employers, with a focus on partnerships in the United States.The revenue model of XP Health revolves around partnerships and direct-to-consumer transactions, leveraging subscriptions for their vision care services. The company generates income through contracts with employers who sponsor vision care benefits for their employees and through direct sales of personalized eyewear facilitated by their platform. The transaction structure includes B2B agreements with employers, ensuring that employees can easily access and use their vision care benefits, which are tailored to different organizational needs.In August 2024, XP Health, Inc. raised USD 25.20 mn in Series B funding, which will be used to expand its product range and enhance its marketing and sales initiatives. The company aims to reach more employers and distribution partners across the country. Specific plans for future growth include developing new products to be launched in the coming years, focusing on increased market penetration in the US and potentially exploring opportunities in international markets.

## Funding rounds

- Series B, Aug 23, 2024, $25M — QED Investors, Valor Capital Group, American Family Ventures, Canvas Prime, ManchesterStory, SemperVirens, HC9 Ventures
- Series A, Sep 28, 2022, $17M — GSR Ventures, Core Innovation Capital, Plug and Play, Valor Capital Group, Canvas Prime, ManchesterStory, Cameron Ventures, HC9 Ventures
- Seed, Jan 19, 2021, $5M — Valor Capital Group, StartX, Village Global, J-Ventures, SemperVirens

## Investors

- Valor Capital Group (https://capitalatlas.ai/funds/valor-capital-group) — Seed, Series A, Series B
- StartX — Seed
- Village Global (https://capitalatlas.ai/funds/village-global) — Seed
- J-Ventures (https://capitalatlas.ai/funds/j-ventures) — Seed
- SemperVirens (https://capitalatlas.ai/funds/sempervirens) — Seed, Series B
- GSR Ventures (https://capitalatlas.ai/funds/gsr-ventures) — Series A
- Core Innovation Capital (https://capitalatlas.ai/funds/core-innovation-capital) — Series A
- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Series A
- Canvas Prime (https://capitalatlas.ai/funds/canvas-prime) — Series A, Series B
- ManchesterStory (https://capitalatlas.ai/funds/manchesterstory) — Series A, Series B
- Cameron Ventures (https://capitalatlas.ai/funds/cameron-ventures) — Series A
- HC9 Ventures (https://capitalatlas.ai/funds/hc9-ventures) — Series A, Series B
- QED Investors (https://capitalatlas.ai/funds/qed-investors) — Series B
- American Family Ventures (https://capitalatlas.ai/funds/american-family-ventures) — Series B